Workflow
科兴制药: 公司章程

Core Points - The articles outline the articles of association for Kexing Biopharm Co., Ltd., detailing the company's legal framework, governance structure, and operational guidelines [2][4][5]. Group 1: General Provisions - The company is established as a joint-stock limited company in accordance with the Company Law and other relevant regulations [2][3]. - The registered capital of the company is RMB 201,257,250.00 [3]. - The company is permanently established and has its legal representative as the chairman [3][4]. Group 2: Business Objectives and Scope - The company's mission is to promote the development of high-quality biopharmaceuticals and enhance their clinical value, focusing on safety and reliability for patients [5]. - The business scope includes research, production, and sales of biological products, chemical drugs, raw materials, and traditional Chinese medicine, among others [5]. Group 3: Shares - The company has issued a total of 201,257,250 shares, all of which are ordinary shares denominated in RMB [6][20]. - The issuance of shares follows principles of openness, fairness, and justice, ensuring equal rights for all shares of the same category [6][7]. Group 4: Shareholder Rights and Responsibilities - Shareholders have rights to dividends, attend meetings, supervise the company, and access company documents [13][34]. - Shareholders are obligated to comply with laws and regulations, pay for their subscribed shares, and not abuse their rights to harm the company or other shareholders [40][41]. Group 5: Shareholder Meetings - The company holds annual and temporary shareholder meetings, with the annual meeting required to be held within six months after the end of the fiscal year [21][52]. - Shareholder meetings can be convened by the board of directors or at the request of shareholders holding more than 10% of the shares [56][61]. Group 6: Decision-Making and Voting - Major decisions, such as capital increases, mergers, and significant asset transactions, require approval from the shareholders' meeting [21][49]. - Voting procedures and requirements for decision-making are clearly defined, ensuring transparency and accountability [30][34].